Iofina plc

LSE IOF.L

Iofina plc Price to Sales Ratio (P/S) on January 14, 2025: 0.90

Iofina plc Price to Sales Ratio (P/S) is 0.90 on January 14, 2025, a -23.03% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Iofina plc 52-week high Price to Sales Ratio (P/S) is 1.38 on February 07, 2024, which is 53.08% above the current Price to Sales Ratio (P/S).
  • Iofina plc 52-week low Price to Sales Ratio (P/S) is 0.69 on December 20, 2024, which is -23.40% below the current Price to Sales Ratio (P/S).
  • Iofina plc average Price to Sales Ratio (P/S) for the last 52 weeks is 1.02.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
LSE: IOF.L

Iofina plc

CEO Dr. Thomas Matthew Becker
IPO Date May 9, 2008
Location United Kingdom
Headquarters 48 Chancery Lane
Employees 108
Sector Industrials
Industries
Description

Iofina plc engages in the exploration and production of iodine, iodine specialty chemical derivatives, produced water, and natural gas in the United States and the United Kingdom. It offers halogen chemicals, disinfectants, electronic specialty gases, sanitizers, heat stabilizers, preservatives, and specialty intermediates, as well as animal health, mineral separation, and odor control products for use in electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, and nylon markets. The company also provides turnkey mid-stream fee based solutions to third party brine stream operators to extract iodine. Iofina plc was founded in 2005 and is based in London, the United Kingdom.

Similar companies

IQE.L

IQE plc

USD 0.14

0.09%

SQZ.L

Serica Energy plc

USD 1.88

-0.75%

FUM.L

Futura Medical plc

USD 0.37

-1.16%

StockViz Staff

January 15, 2025

Any question? Send us an email